Website
Business classification
VCID: 111470
Profile
Corporate information
Official name
Orphazyme ApS
Registration country
Official name
Orphazyme ApS
Registration country
Investment activity status
Active investor
Company type
Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases.Funding
Funding rounds
Series A USD 20,000,000
USD 20,000,000 (1 Sep 2011) Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Aescap Venture Management BV | Venture capital company investing in private medical companies in Europe | Netherlands | Initial investment. Round participant. |
|
Novo A/S | Denmark | Follow-on investment. Round participant. | |
|
Sunstone Capital AS | Denmark | Follow-on investment. Round participant. |
Seed DKK 22,000,000
(14 Feb 2011) Change in valuation: up round
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
Novo A/S | Denmark | Initial investment. Round participant. | |
|
|
Sunstone Capital AS | Denmark | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Aescap Venture Management BV Venture capital company investing in private medical companies in Europe |
+31 (20) 570-2940 |
Series A |
|
|
Novo A/S |
Seed Series A |
|
|
|
Sunstone Capital AS |
Seed Series A |